InsiderTrades.com logo
Urgent: This election is rigged
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.
Remy Sukhija net worth and biography
  • Phone
  • Email
  • Website

Remy Sukhija Biography and Net Worth

Sr. VP & Chief Commercial Officer of Madrigal Pharmaceuticals
Remy Sukhija is the Sr. VP & Chief Commercial Officer at Madrigal Pharmaceuticals Inc.

How do I contact Remy Sukhija?

The corporate mailing address for Mr. Sukhija and other Madrigal Pharmaceuticals executives is 200 BARR HARBOR DRIVE SUITE 400, WEST CONSHOHOCKEN PA, 19428. Madrigal Pharmaceuticals can also be reached via phone at (267) 824-2827 and via email at [email protected]. Learn More on Remy Sukhija's contact information.

Has Remy Sukhija been buying or selling shares of Madrigal Pharmaceuticals?

Remy Sukhija has not been actively trading shares of Madrigal Pharmaceuticals during the last quarter. Most recently, Remy Sukhija sold 30,000 shares of the business's stock in a transaction on Friday, December 23rd. The shares were sold at an average price of $274.14, for a transaction totalling $8,224,200.00. Learn More on Remy Sukhija's trading history.

Who are Madrigal Pharmaceuticals' active insiders?

Madrigal Pharmaceuticals' insider roster includes Fred Craves (Director), James Daly (Director), Paul Friedman (Director), Richard Levy (Director), Brian Lynch (SVP), William Sibold (CEO), Remy Sukhija (Sr. VP & Chief Commercial Officer), Rebecca Taub (Director, Founder, Chief Medical Officer and President of Research & Development), and Robert Waltermire (VP). Learn More on Madrigal Pharmaceuticals' active insiders.

Are insiders buying or selling shares of Madrigal Pharmaceuticals?

During the last twelve months, Madrigal Pharmaceuticals insiders bought shares 1 times. They purchased a total of 81,159 shares worth more than $17,805,473.01. During the last twelve months, insiders at the biopharmaceutical company sold shares 16 times. They sold a total of 193,584 shares worth more than $42,301,962.98. The most recent insider tranaction occured on November, 1st when Director Richard S Levy sold 5,000 shares worth more than $1,504,700.00. Insiders at Madrigal Pharmaceuticals own 22.8% of the company. Learn More about insider trades at Madrigal Pharmaceuticals.

Information on this page was last updated on 11/1/2024.

Remy Sukhija Insider Trading History at Madrigal Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/23/2022Sell30,000$274.14$8,224,200.00View SEC Filing Icon  
See Full Table

Remy Sukhija Buying and Selling Activity at Madrigal Pharmaceuticals

This chart shows Remy Sukhija's buying and selling at Madrigal Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Madrigal Pharmaceuticals Company Overview

Madrigal Pharmaceuticals logo
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.
Read More

Today's Range

Now: $347.45
Low: $322.73
High: $351.07

50 Day Range

MA: $250.25
Low: $202.48
High: $354.85

2 Week Range

Now: $347.45
Low: $168.25
High: $368.29

Volume

537,369 shs

Average Volume

444,100 shs

Market Capitalization

$7.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Urgent: This election is rigged
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.